share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.9%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.9%)

SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(4.9%)
美股sec公告 ·  05/08 14:24
Moomoo AI 已提取核心訊息
On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.
On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.
2024年4月30日，總部位於特拉華州的投資管理公司貝萊德公司向美國證券交易委員會（SEC）提交了經修訂的附表13G，表明其持有的Cardio Diagnostics Holdings Inc.普通股發生了變化。該文件是1934年《證券交易法》對某些所有權門檻的要求，顯示貝萊德現在實益擁有1,067,062股股票，佔公司普通股類別的4.9％。這標誌着所有權的減少，因爲貝萊德已經勾選了表明其持有該類別證券的比例不再超過5％的複選框。該文件由貝萊德公司事實律師斯賓塞·弗萊明簽署，據簽署人所知，所提供的信息經認證爲真實和完整。
2024年4月30日，總部位於特拉華州的投資管理公司貝萊德公司向美國證券交易委員會（SEC）提交了經修訂的附表13G，表明其持有的Cardio Diagnostics Holdings Inc.普通股發生了變化。該文件是1934年《證券交易法》對某些所有權門檻的要求，顯示貝萊德現在實益擁有1,067,062股股票，佔公司普通股類別的4.9％。這標誌着所有權的減少，因爲貝萊德已經勾選了表明其持有該類別證券的比例不再超過5％的複選框。該文件由貝萊德公司事實律師斯賓塞·弗萊明簽署，據簽署人所知，所提供的信息經認證爲真實和完整。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息